Gala Therapeutics Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$100M
- Investors
-
1
Gala Therapeutics General Information
Description
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with lung cancer, COPD (Chronic Obstructive Pulmonary Disease), asthma, and other pulmonary diseases. The company's system offers a single-use catheter and electrosurgical generator to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients, enabling physicians to treat their patients better, resulting in a better medical outcome.
Contact Information
Website
www.galatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 1531 Industrial Road
- Suite 100
- San Carlos, CA 94070
- United States
+1 (650) 000-0000
Gala Therapeutics Timeline
Gala Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 29-Mar-2022 | $100M | 00000 | 00000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 18-Nov-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
Gala Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Gala Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with l
Therapeutic Devices
San Carlos, CA
39
As of 2021
00000
0000
0000-00-00
00000000000
00000
000000
isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
00000000000 0000000
Lexington, MA
00
As of 0000
00000
00000000000
00000
000000
ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 0000000 000 00000000
Redwood City, CA
000
As of 0000
00000
0000
0000-00-00
00000000
00000
Add Comparison
Gala Therapeutics Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RejuvenAir | Venture Capital-Backed | Lexington, MA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000 | 00000 |
| 0000000 | Venture Capital-Backed | Minneapolis, MN | 00 | 00000 | 0000000000 0 | 00000 |
Gala Therapeutics Executive Team (4)
Gala Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Douglas Godshall | Self | Co-Chairman | 000 0000 |
| Jonathan Waldstreicher MD | Self | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Seth Harrison MD | Self | Co-Chairman | 000 0000 |
Gala Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Gala Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ATP (Apple Tree Partners) | Venture Capital | Minority | 000 0000 | 000000 0 |